|
||
|
||
| [Home Page] [Previous Menu] [Search] |
B-GT/4: Regulatory and clinical data
(Authors: M. Sneyers and M. Goossens - Last revised:
February 28, 2006
)
Title |
A phase II gene therapy study in patients with non-small cell lung cancer using SCH58500 (rAd/p53) in combination with chemotherapy for multiple cycles |
Company or sponsor |
Schering Plough NV/SA |
Pharmaceutical study code |
I97-076-03 |
Phase |
II |
Unicenter/multicenter study |
multicenter |
| Clinical data | see table 2 |
Installation |
Akademisch Ziekenhuis, Vrije Universiteit Brussel |
Authorisation procedure |
contained use, first use (see relevant regulation) |
Application number |
SBB 219 97/0919 |
User(s) |
Prof. Dr J. De Grève |
Receipt date |
18/08/1997 |
Biosafety Council meeting date |
- |
Authorisation date |
12/02/1998 |
Status |
trial completed |
|